Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06541340

A New Strategy for Preoperative Drainage of Resectable Pancreatic Head Cancer Combined Severe Obstructive Jaundice

A New Strategy for Preoperative Drainage of Resectable Pancreatic Head Cancer Combined Severe Obstructive Jaundice, a Multicenter, Open-label, Randomized Controlled Clinical Study

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
360 (estimated)
Sponsor
Ruijin Hospital · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

Severe obstructive jaundice caused by pancreatic head cancer usually requires preoperative biliary drainage, but its necessity and effectiveness are controversial, and specific strategies lack clear standards. This study proposed a new strategy for preoperative biliary drainage using serum prealbumin as the main evaluation index, and compared it with the traditional strategy using serum total bilirubin as the main evaluation index. Through a randomized, controlled, multicenter prospective study, we explored the effects of different drainage strategies on the incidence of in-hospital complications and long-term prognosis of patients with resectable pancreatic head cancer, guided clinical decisions on preoperative drainage time and surgical timing, and provided high-quality evidence-based medicine for preoperative biliary drainage of pancreatic head cancer.

Conditions

Interventions

TypeNameDescription
PROCEDUREModified strategyModified preoperative biliary drainage strategy with prealbumin as the main indicator
PROCEDURETraditional strategyTraditional preoperative biliary drainage strategy with total bilirubin as the main indicator

Timeline

Start date
2024-08-01
Primary completion
2026-12-31
Completion
2026-12-31
First posted
2024-08-07
Last updated
2024-08-07

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06541340. Inclusion in this directory is not an endorsement.